Nitric oxide discriminates the sites and mechanisms of action of centrally acting anti-hypertensive drugs in rabbits

Neuropharmacology

Volumn 43, Issue 8, 2002, Pages 1330-1338

  Sy, Guata Yoro ^a   Bruban, Véronique ^a   Bousquet, Pascal ^a   Feldman, Josiane ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Blood pressure regulation; Catecholamines; Imidazoline receptors; Imidazolines; Nitric oxide; 2 adrenergic receptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; BICUCULLINE; BRIMONIDINE; CORBADRINE; IMIDAZOLINE I1 RECEPTOR; N(G) NITROARGININE; NITRIC OXIDE; PENTOBARBITAL; RAUWOLSCINE; S 23757; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; HYPOTENSION; LATERAL RETICULAR NUCLEUS; MALE; MEAN ARTERIAL PRESSURE; MEDULLA OBLONGATA; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR AFFINITY; SOLITARY TRACT NUCLEUS;

EID: 0036946657     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00307-6     Document Type: Article

References (38)

1. 3H]Cirazoline as a tool for the characterization of imidazoline sites. Annals of the New York Academy of Sciences. 763:1995;112-124.
2. Bains J.S., Ferguson A.V. Nitric oxide depolarizes type II paraventricular nucleus neurons in vitro. Neuroscience. 79:1997;149-159.
3. Bousquet P. Imidazoline receptors - Commentary. Neurochemistry International. 30:1997;3-7.
4. Bousquet P., Feldman J., Bloch R., Schwartz J. The nucleus reticularis lateralis: a region highly sensitive to clonidine. European Journal of Pharmacology. 69:1981;389-392.
5. Bousquet P., Feldman J., Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. Journal of Pharmacology and Experimental Therapeutics. 230:1984;232-236.
6. Bousquet P., Bruban V., Schann S., Feldman J. Imidazoline receptors: a challenge. Pharmaceutica Acta Helvetiae. 74:2000;205-209.
7. Bruban V., Feldman J., Greney H., Dontenwill M., Schann S., Jarry C., Payard M., Boutin J., Scalbert E., Pfeiffer B., Renard P., Vanhoutte P., Bousquet B. Respective contributions of α-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs. British Journal of Pharmacology. 133:2001;261-266.
8. Chan R.K.W., Sawchenko P.E. Organization and transmitter specificity of medullary neurons activated by sustained hypertension: implications for understanding baroreceptors reflex circuitry. Journal of Neuroscience. 18:(1):1998;371-387.
9. Dampney R.A.L. Functional organization of central pathways regulating the cardiovascular system. Physiological Review. 74:1994;323-364.
10. Dampney R.A.L., Goodchild A.K., Robertson L.G., Montgomery W. Role of ventrolateral medulla in vasomotor regulation: a correlative anatomical and physiological study. Brain Research. 249:1982;223-235.
11. Dampney R.A.L., Czachurski J., Dembowsky K., Goodchild A.K., Seller H. Afferent connections and spinal projections of the vasopressor region in the rostral ventrolateral medulla of the cat. Journal of Autonomic Nervous System. 20:1987;73-86.
12. De Jong W., Nijkamp F.P. Central induced hypotension and bradycardia after administration of α-methylnoradrenaline into the area of the nucleus tractus solitarii of the rat. British Journal of Pharmacology. 58:1976;593-598.
13. Dobrucki L.W., Cabrera C.L., Bohr D.F., Malinski T. Central hypotensive action of clonidine requires nitric oxide. Circulation. 104:2001;1884-1886.
14. 1-imidazoline receptor agonist. Journal of Cardiovascular Pharmacology. 35:(Suppl. 4):2000;S27-S41.
15. Ernsberger P., Guiliano R., Willette R.N., Reis D.J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. Journal of Pharmacology and Experimental Therapeutics. 253:1990;408-418.
16. Feldman J., Tibiriça E., Bricca G., Dontenwill M., Belcourt A., Bousquet P. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. British Journal of Pharmacology. 100:1990;600-604.
17. Feldman J., Greney H., Monassier L., Vonthron C., Bruban V., Dontenwill M., Bousquet P. Does a second generation of centrally acting antihypertensive drugs really exist? Journal of Autonomic Nervous System. 72:1998;94-97.
18. Hall C.W., Behbehani M.M. Synaptic effects of nitric oxide on enkephalinergic, GABAergic, and glutamatergic networks of the rat periaqueductal gray. Brain Research. 805:1998;69-87.
19. Head G.A., Burke S.L. Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetized rabbit. Journal of Hypertension. 16:1998;503-517.
20. Ishide T., Hara Y., Maher T.Y., Ally A. Glutamate neurotransmission and nitric oxide interaction within the ventrolateral medulla during cardiovascular responses to muscle contraction. Brain Research. 874:2000;107-115.
21. 3H]aspartate from rat hippocampal slices. Journal of Neurochemistry. 64:(5):1995;2057-2063.
22. Kano T., Shimizu-Sasamata M., Huang P.L., Moskowitz M.A., Lo E.H. Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo. Neuroscience. 86:(3):1998;695-699.
23. Lawrence A.J., Jarrott B. Nitric oxide increases intersticial excitatory amino acid release in the rat dorsomedial medulla oblongata. Neuroscience Letters. 151:1993;126-129.
24. Lawrence A.J., Krstew E., Jarott B. Actions of nitric oxide and expression of the mRNA encodding nitric oxide synthase in rat vagal afferent neurons. European Journal of Pharmacology. 315:1996;127-133.
25. Lawrence A.J. Nitric oxide as a modulator of medullary pathways. Clinical and Experimental Pharmacology and Physiology. 24:1997;760-763.
26. Louis W.J., Conway E., Summer R., Beart P., Jarrott B. Effect of methyldopa metabolites on amine tansmitters and adrenergic receptors in rat brain. Hypertension. 6:(Suppl. II):1984;1140-1144.
27. Ma S., Long J.P. Central noradrenergic activity is responsible for nitroglycerin-induced cardiovascular effects in the nucleus tractus solitarii. Brain Research. 559:1991;297-303.
28. Nauli M.S., Pearce W.J., Amer A., Maher T.J., Ally A. Effects of nitric oxide and GABA interaction within ventrolateral medulla on cardiovascular responses during static muscle contraction. Brain Research. 922:2001;234-242.
29. 3H]brimonidine. Brain Research. 475:1988;361-365.
30. Reis D.J., Granata A.R., Joh T.H., Ross C.A., Ruggiero D.A., Park D.H. Brainstem catecholamine mechanism in tonic and reflex control of blood pressure. Hypertension. 6:1984;7-15.
31. Ross C.A., Ruggiero D.A., Reis D.J. Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla. Journal of Comparative Neurology. 242:1985;511-534.
32. Spyer K.M. Central nervous mechanisms contributing to cardiovascular control. Journal of Physiology. 474:1994;1-19.
33. Sun M.K., Hackett J.T., Guyenet P.G. Sympathoexcitatory neurons of rostral ventrolateral medulla exhibit pacemaker properties in the presence of a glutamate-receptors antagonist. Brain Research. 438:1988;23-40.
34. Sy G.Y., Bruban V., Bousquet P., Feldman J. Nitric oxide and central antihypertensive drugs. One more difference between catecholamines and imidazolines. Hypertension. 37:(2):2001;246-249.
35. Tolentino-Silva F.P., Haxhiu M.A., Waldbaum S., Dreshaj I.A., Ernsberger P. Alpha (2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice. Brain Research. 862:(1-2):2000;26-35.
36. Zandberg P., De Jong W., De Wied D. Effect of catecholamine-receptor stimulating agents on blood pressure after local application in the nucleus tractus solitarii of the medulla obonglata. European Journal of Pharmacology. 55:1979;43-56.
37. Zanzinger J., Czachurski J., Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. American Journal of Physiology. 268:1995;R958-R962.
38. Zhang K., Patel K.P. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. American Journal of Physiology. 275:1998;R728-R734.